The study, conducted by the Plasma Protein Therapeutics Association and analyzed by SSRS, surveyed 1,167 individuals to assess the impact of plasma-derived medicines. Data reveals that 69% of patients or their caregivers noticed health changes within a few months of treatment, while 26% reported improvements in just a few days. For many, these therapies are not sporadic interventions but a recurring necessity; 41% of respondents require weekly infusions to manage conditions such as primary immunodeficiencies, bleeding disorders, and neurological illnesses.
In section Releases
Global Survey Highlights Patient Reliance on Plasma Therapies
Seventy-seven percent of patients and caregivers express profound gratitude toward plasma donors, according to a new global survey released for International Plasma Awareness Week. The findings underscore the critical role these therapies play in managing chronic conditions, with most patients reporting significant health improvements shortly after beginning treatment.
Beyond clinical outcomes, the survey highlights a strong sense of connection between those receiving care and the donors who provide it. With 87% of patients expressing confidence in the safety and efficacy of their treatments, the results serve as a focal point for this year’s awareness campaign. PPTA President Anita Brikman noted that the data puts the life-changing impact of these therapies into perspective, bridging the gap between donor generosity and the daily lives of patients like Christy Savino, who relies on plasma medication to manage a primary immunodeficiency.
Comments (0)
No comments yet. Be the first!